Effect of Saphenous Vein Diameter on Closure Rate With ClosureFAST Radiofrequency Catheter

Abstract

Purpose: Radiofrequency ablation (RFA) of veins >12 mm in diameter has been a controversial subject since the first-generation device was submitted for Food and Drug Administration (FDA) approval. Veins >12 mm were excluded in the initial study. Many insurance carriers used >12 mm size as reason to not approve the procedure. As the concept of tumescent anesthesia was better communicated, RFA was used for large veins. The 12-mm size limit was not used in the studies for the newer ClosureFAST catheter approval, yet remains in force with some insurance companies. Our objective was to determine whether vein diameter >12 mm had effect on closure rates with the Closure-FAST catheter. Methods: ClosureFAST RFA was used to eliminate saphenous reflux in consecutive cases in 1 center. Retrospective analysis was performed on prospectively gathered data. Veins were divided into ≤12 mm diameter (group A) or >12 mm diameter (group B). Duplex scans were scheduled for 2 to 5 days and 6 months postprocedure. Results: A total of 338 great and small saphenous veins were treated, 246 saphenous veins in group A (mean 8 ± 2 mm) and 96 in group B (mean 17 ± 4 mm). Early duplex showed complete closure in 231 veins in group A (94%) and 92 veins in group B (96%; NS). The remaining veins showed partial closure with none showing retrograde flow. Six-month duplex scans were completed in 155 veins. Complete closure was seen in 110 veins in group A (98%) and 43 veins in group B (100%; NS). All veins partially open on early scan had closed by 6 months. The 2 veins open at 6 months in group A were closed on initial scan. Conclusions: Vein diameter >12 mm had no effect on closure rate with the ClosureFAST catheter.

Keywords

varicose veins radiofrequency ablation saphenous vein

Get full access to this article

View all access options for this article.

References

Merchant RF , Pinchot O. ,. and the Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg . 2005;42(3): 502-509; discussion 509.

Manfrini S. , Gasbarro V. , Danielsson G. , et al. for the Endovenous Reflux Management Study Group. Endovenous management of saphenous vein reflux. J Vasc Surg. 2000;32(2):330-342.

Merchant RF , Pinchot O. , Myers KA Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux. Dermatol Surg. 2005;31(2):129-134.

Elias S. Endovenous radiofrequency technique with peri-venous tumescent anesthesia for obliteration of large diameter great saphenous veins. ACP 19th Annual Congress. Abstract P106; November 2005; San Francisco.

Niedzwiecki G. RFA of large Greater Saphenous Vein. Society for Interventional Radiology (SIR). Abstract S145; March 2004 ; Phoenix, AZ, USA.

Sichlau M. RFA of Large Greater Saphenous Vein. Society for Interventional Radiology (SIR). Abstract, S212; March 2004 ; Phoenix, AZ, USA.

Proebstle TM , Vago B. , Alm J. , Göckeritz O. , Lebard C. , Pichot O. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg. 2008;47(1):151-156.

Arkansas BlueCross BlueShield Coverage Policy Manual. 2007; Little Rock, AR, USA.

Highmark Medicare Services. 2008. Local coverage determinations (LCD L27539) Treatment of varicose veins of the lower extremities, www.highmarkmedicareservices.com